Changing patterns in the selection of viral mutations among patients receiving nucleoside and nucleotide drug combinations directed against human immunodeficiency virus type 1 reverse transcriptase

Antimicrob Agents Chemother. 2005 May;49(5):1671-8. doi: 10.1128/AAC.49.5.1671-1678.2005.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-HIV Agents / therapeutic use*
  • Drug Resistance, Viral
  • HIV Infections / drug therapy*
  • HIV Infections / virology*
  • HIV-1 / enzymology
  • HIV-1 / genetics*
  • Humans
  • Mutation / genetics*
  • Nucleosides / therapeutic use*
  • Nucleotides / therapeutic use*
  • Reverse Transcriptase Inhibitors / therapeutic use*

Substances

  • Anti-HIV Agents
  • Nucleosides
  • Nucleotides
  • Reverse Transcriptase Inhibitors